Efficacy of sorafenib combined with transarterial chemoembolization in the treatment of advanced hepatocellular carcinoma: A meta-analysis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

239

Figures (1-6)

Tables (1-2)

Sum=412

Publishing Process of This Article

Item

Count

Browse

Download

Sum=38

Feb 15, 2025 (publication date) through Feb 21, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastrointest Oncol. Feb 15, 2025; 17(2): 98927
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.98927

Full Size Figure Download Figure

Figure 3 Forest plot showing the impact of combining sorafenib with transarterial chemoembolization on overall survival.

Citation: Xu M, Zhou SR, Li YL, Zhang CH, Liao DZ, Wang XL. Efficacy of sorafenib combined with transarterial chemoembolization in the treatment of advanced hepatocellular carcinoma: A meta-analysis. World J Gastrointest Oncol 2025; 17(2): 98927
URL: https://www.wjgnet.com/1948-5204/full/v17/i2/98927.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i2.98927